SPIA
YARW

Steward Partners Investment Advisory’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Steward Partners Investment Advisory’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– -$51 – 3683
2023
Q4 		– Hold
0
– – – 3460
2023
Q3 		– Hold
0
– – – 3321
2023
Q2 		– Hold
0
– – – 3272
2023
Q1 		– Sell
-1
Closed -$180 – 3264
2022
Q4 		$95 Hold
1
– – ﹤0.01% 3297
2022
Q3 		$0 Hold
1
– – ﹤0.01% 3398
2022
Q2 		$0 Hold
1
– – ﹤0.01% 3384
2022
Q1 		$1K Sell
1
-1
-50% -$594 ﹤0.01% 3230
2021
Q4 		$2K Sell
2
-2
-50% -$2.15K ﹤0.01% 3039
2021
Q3 		$5K Hold
4
– – ﹤0.01% 2825
2021
Q2 		$13K Sell
4
-4
-50% -$15.8K ﹤0.01% 5671
2021
Q1 		$48.3K Buy
8
+3
+60% +$21.8K ﹤0.01% 2003
2020
Q4 		$27K Sell
5
-1
-17% -$6.28K ﹤0.01% 1958
2020
Q3 		$37K Sell
6
-1
-14% -$5.83K ﹤0.01% 1641
2020
Q2 		$45K Buy
7
+4
+133% +$27.1K ﹤0.01% 1461
2020
Q1 		$32K Buy
+3
New +$47.1K ﹤0.01% 1436

Other funds holding YARW

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Steward Partners Investment Advisory's YARW Position: Q1 2024 in Review

Steward Partners Investment Advisory held its Yarrow Bioscience, Inc. Common Stock (YARW) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

Steward Partners Investment Advisory first reported a position in YARW in Q1 2020 and has held it in 12 quarters since. The position peaked at $48.3K in Q1 2021. 30 funds tracked by Wall St. Rank hold YARW as of Q1 2024.

  • Steward Partners Investment Advisory held 0 shares of Yarrow Bioscience, Inc. Common Stock worth $0 as of Q1 2024.
  • Steward Partners Investment Advisory left its Yarrow Bioscience, Inc. Common Stock share count unchanged in Q1 2024.
  • Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2024, its #3683 holding.
  • Steward Partners Investment Advisory first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2020 and has held it in 12 quarters since.
  • Steward Partners Investment Advisory's Yarrow Bioscience, Inc. Common Stock position peaked at $48.3K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2024, filed 15 May 2024.